Insulin resistance has been identified as a key driver of CVD and other complications in people living with HIV.
Knowing the advantages and drawbacks of available HIV tests and how best to use them can make HIV test selection a less intimidating process.
What are some advances on the horizon that may impact infectious disease specialists and their patients? We offer our 2019 predictions in medicine.
Although HAART has enabled people infected with HIV to achieve normal life expectancies, its use has been associated with bone health problems.
Immunosuppression increases the risk for human papillomavirus infection in patients infected with HIV.